tiprankstipranks
Trending News
More News >
Lantheus (LNTH)
NASDAQ:LNTH
US Market

Lantheus (LNTH) Earnings Dates, Call Summary & Reports

Compare
1,394 Followers

Earnings Data

Report Date
Jul 31, 2025
TBA Not Confirmed
Period Ending
2025 (Q2)
Consensus EPS Forecast
1.69
Last Year’s EPS
1.8
Same Quarter Last Year
Based on 9 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:May 07, 2025
|
% Change Since: -22.51%
|
Next Earnings Date:Jul 31, 2025
Earnings Call Sentiment|Neutral
The earnings call presented a mixed outlook, with strategic acquisitions and pipeline advancements highlighting potential for future growth. However, competitive pressures on PYLARIFY, flat revenue growth, and decreased profit margins weighed on the overall sentiment. The company also lowered its full-year guidance, reflecting challenges in the current market environment.
Company Guidance
During the Lantheus First Quarter 2025 Conference Call, the company provided guidance on several key metrics. They announced plans to divest their SPECT business to SHINE Technologies and highlighted two acquisitions: Evergreen Theragnostics and Life Molecular Imaging, which are expected to drive revenue growth and diversify their portfolio. The acquisitions are anticipated to enhance their radiopharmaceutical leadership and add capabilities, including infrastructure for manufacturing radiotherapeutics. The company projects the U.S. Alzheimer’s disease radiodiagnostics market could grow to more than $1.5 billion by the end of the decade and $2.5 billion by the mid-2030s. For PYLARIFY, sales for the quarter were $258 million with plans to maintain market leadership despite competitive pressures. The fiscal year 2025 guidance for PYLARIFY was updated to flat-to-low single-digit percent growth, with expectations for total net revenue to be between $1.55 billion and $1.585 billion. Adjusted EPS is expected to range from $6.60 to $6.70, down from the previous guidance of $7 to $7.20, due to strategic investments and acquisitions. The company expressed confidence in sustainable long-term growth, driven by their diversified pipeline and strategic focus.
Strategic Acquisitions and Divestitures
Announced the acquisition of Evergreen Theragnostics and Life Molecular Imaging, aimed at enhancing radiopharmaceutical capabilities and growth. Also announced the divestment of the SPECT business to SHINE Technologies.
Strong Product Performance
PYLARIFY sales for the first quarter were $258 million, despite a low-single-digit decline in net price. DEFINITY achieved approximately $79 million in sales, even with the return of competitive supply to the U.S. market.
Positive Pipeline Developments
MK-6240, a next-generation tau imaging agent, met its primary endpoints in two pivotal studies. The company plans to submit a new drug application to the FDA in the third quarter of 2025.
Financial Stability
Operating cash flow for the first quarter was $107.6 million, with a strong liquidity position of $938.5 million in cash and cash equivalents.
---

Lantheus (LNTH) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

LNTH Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Jul 31, 2025
2025 (Q2)
1.69 / -
1.8
May 07, 2025
2025 (Q1)
1.66 / 1.53
1.69-9.47% (-0.16)
Feb 26, 2025
2024 (Q4)
1.54 / 1.59
1.75-9.14% (-0.16)
Nov 06, 2024
2024 (Q3)
1.56 / 1.70
1.4715.65% (+0.23)
Jul 31, 2024
2024 (Q2)
1.83 / 1.80
1.5416.88% (+0.26)
May 02, 2024
2024 (Q1)
1.54 / 1.69
1.4714.97% (+0.22)
Feb 22, 2024
2023 (Q4)
1.43 / 1.75
1.3727.74% (+0.38)
Nov 02, 2023
2023 (Q3)
1.32 / 1.47
0.9948.48% (+0.48)
Aug 03, 2023
2023 (Q2)
1.31 / 1.54
0.8973.03% (+0.65)
May 04, 2023
2023 (Q1)
1.29 / 1.47
0.9751.55% (+0.50)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

LNTH Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
May 07, 2025
$104.84$80.49-23.23%
Feb 26, 2025
$80.05$93.25+16.49%
Nov 06, 2024
$114.96$91.17-20.69%
Jul 31, 2024
$109.77$104.83-4.50%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does Lantheus (LNTH) report earnings?
Lantheus (LNTH) is schdueled to report earning on Jul 31, 2025, TBA Not Confirmed.
    What is Lantheus (LNTH) earnings time?
    Lantheus (LNTH) earnings time is at Jul 31, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is LNTH EPS forecast?
          LNTH EPS forecast for the fiscal quarter 2025 (Q2) is 1.69.
            ---

            Lantheus (LNTH) Earnings News

            Lantheus Blasts Up as Earnings Impress
            Premium
            Market News
            Lantheus Blasts Up as Earnings Impress
            2y ago
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis